“A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report”. 2026. Journal of Pharma Insights and Research 4 (2): 252-58. https://doi.org/10.69613/ss2yp015.